Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly J Butnor

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The American Journal of Pathology|January 4, 2007
Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout miceArti Shukla, Karen M Lounsbury, Trisha F Barrett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2022
The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 ClassificationJennifer L Sauter, Sanja Dacic, Francoise Galateau-Salle, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 23, 2012
A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasSherrill L Macura, Jedd M Hillegass, Jeremy L Steinbacher, et al.
BMC Cancer|September 13, 2013
Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsSherrill L Macura, Jeremy L Steinbacher, Maximilian B Macpherson, et al.
Archives of Pathology & Laboratory Medicine|February 27, 2018
Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting PathologistAndrew G Nicholson, Ming S Tsao, William D Travis, et al.
Histopathology|July 3, 2020
Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studiesJennifer L Sauter, Marina K Baine, Kelly J Butnor, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2020
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 casesDavid B Chapel, Jefree J Schulte, Gudrun Absenger, et al.
International Journal of Cancer|September 11, 2010
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyJedd M Hillegass, Steven R Blumen, Kai Cheng, et al.
JCI Insight|July 1, 2016
Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-<i>S</i>-transferase πDavid H McMillan, Jos Lj van der Velden, Karolyn G Lahue, et al.
Science Translational Medicine|October 14, 2021
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19Felice D'Agnillo, Kathie-Anne Walters, Yongli Xiao, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The American Journal of Pathology|January 4, 2007
Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout miceArti Shukla, Karen M Lounsbury, Trisha F Barrett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2022
The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 ClassificationJennifer L Sauter, Sanja Dacic, Francoise Galateau-Salle, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 23, 2012
A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasSherrill L Macura, Jedd M Hillegass, Jeremy L Steinbacher, et al.
BMC Cancer|September 13, 2013
Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsSherrill L Macura, Jeremy L Steinbacher, Maximilian B Macpherson, et al.
Archives of Pathology & Laboratory Medicine|February 27, 2018
Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting PathologistAndrew G Nicholson, Ming S Tsao, William D Travis, et al.
Histopathology|July 3, 2020
Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studiesJennifer L Sauter, Marina K Baine, Kelly J Butnor, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 16, 2020
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 casesDavid B Chapel, Jefree J Schulte, Gudrun Absenger, et al.
International Journal of Cancer|September 11, 2010
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyJedd M Hillegass, Steven R Blumen, Kai Cheng, et al.
JCI Insight|July 1, 2016
Attenuation of lung fibrosis in mice with a clinically relevant inhibitor of glutathione-<i>S</i>-transferase πDavid H McMillan, Jos Lj van der Velden, Karolyn G Lahue, et al.
Science Translational Medicine|October 14, 2021
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19Felice D'Agnillo, Kathie-Anne Walters, Yongli Xiao, et al.
Pageof 8